REGISTERED
on 21 May 2024
Last Applicant/ Owned by
411 SWEDELAND ROAD
KING OF PRUSSIA
PA
19406
Serial Number
97705178 filed on 06th Dec 2022
Registration Number
7393135 registered on 21st May 2024
Correspondent Address
Joshua M. Gerben, Esq.
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
GENESIS VECTOR MANUFACTURING SOLUTIONS
Research and development services in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; consulting services in the fields of research and development for gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; research and development of new products for others; process development services in the nature Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Research and development services in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; consulting services in the fields of research and development for gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; research and development of new products for others; process development services in the nature of research and development of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; scientific research and technical research services, namely, production of cell lines for others using lentivirus technology; scientific research and technical research services relating to producing, assaying and purifying recombinant or manipulated lentivirus; Scientific and technical consulting services relating to producing, assaying, and purifying adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; advisory services relating to research and development of gene therapy products and biopharmaceuticals; manufacturing support services for others, namely, cGMP (Current Good Manufacturing Practice) quality control testing in support of biopharmaceutical development and manufacturing; quality control for others; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; material testing; product quality testing; scientific laboratory services; scientific research; research and development in the field of gene therapy acceleration, vector genome copy titers, droplet digital polymerase chain reaction (PCR) and digital polymerase chain reaction (PCR), mass spectrometry, capsid characterization, bioassays, plasmid DNA, and analytics testing in the field of genes and gene therapy
First Use Date in General
22nd Jan 2024
First Use Date in Commerce
22nd Jan 2024
Class [040]
Treatment & Processing of Materials Services
Manufacturing services for others in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals, plasmid DNA production; manufacturing services for others in the fields of mammalian cell banks, plasmids, adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; manufacturing process consulting
First Use Date in General
22nd Jan 2024
First Use Date in Commerce
22nd Jan 2024
Mark Details
Serial Number
No 97705178
Mark Type
No Service Mark
Attorney Docket Number
No 07768-0053
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 21st May 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 21st May 2024 | REGISTERED-PRINCIPAL REGISTER |
| 18th Apr 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 17th Apr 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 29th Feb 2024 | STATEMENT OF USE PROCESSING COMPLETE |
| 29th Feb 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 06th Feb 2024 | TEAS STATEMENT OF USE RECEIVED |
| 06th Feb 2024 | USE AMENDMENT FILED |
| 26th Dec 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 31st Oct 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |